15 CROSBY DRIVE, BEDFORD, MA
Amendment to 2021 Stock Incentive Plan Approved by Stockholders
Annual Report to Security Holders
Ocular Therapeutix to Present SOL-1 Trial Results at Macula Society Meeting
Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
CFO Departure - Donald Notman Takes Medical Leave; Jason Robins Appointed Int...
Other Events
Reports Third Quarter 2025 Financial Results and Business Highlights
Q1
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement